Your browser doesn't support javascript.
loading
Efficacy and Safety of Long-Term Evolocumab Use Among Asian Subjects - A Subgroup Analysis of the Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER) Trial.
Keech, Anthony C; Oyama, Kazuma; Sever, Peter S; Tang, Minao; Murphy, Sabina A; Hirayama, Atsushi; Lu, Chen; Tay, Leslie; Deedwania, Prakash C; Siu, Chung-Wah; Lira Pineda, Armando; Choi, Donghoon; Charng, Min-Ji; Amerena, John; Wan Ahmad, Wan Azman; Chopra, Vijay K; Pedersen, Terje R; Giugliano, Robert P; Sabatine, Marc S.
Affiliation
  • Keech AC; National Health and Medical Research Council Clinical Trials Centre, Sydney Medical School, University of Sydney.
  • Oyama K; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School.
  • Sever PS; Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine.
  • Tang M; International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London.
  • Murphy SA; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School.
  • Hirayama A; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School.
  • Lu C; Division of Cardiology, Department of Medicine, Nihon University School of Medicine.
  • Tay L; Amgen.
  • Deedwania PC; Cardiology Department, Changi General Hospital.
  • Siu CW; University of California San Francisco School of Medicine.
  • Lira Pineda A; Cardiology Division, Department of Medicine, Li Ka Shing Faculty of Medicine, the University of Hong Kong, Hong Kong SAR.
  • Choi D; Amgen.
  • Charng MJ; Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine.
  • Amerena J; Division of Cardiology, Taipei Veterans General Hospital.
  • Wan Ahmad WA; Faculty of Medicine, School of Medicine, National Yang Ming University.
  • Chopra VK; Geelong Cardiology Research Unit, Barwon Health.
  • Pedersen TR; Cardiology Department, University Malaya Medical Center.
  • Giugliano RP; Department of Cardiology, Max Super Speciality Hospital.
  • Sabatine MS; Medical Faculty, Oslo University Hospital Aker.
Circ J ; 85(11): 2063-2070, 2021 10 25.
Article in En | MEDLINE | ID: mdl-33980763

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asian People / Atherosclerosis / Antibodies, Monoclonal, Humanized / PCSK9 Inhibitors Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Circ J Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2021 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asian People / Atherosclerosis / Antibodies, Monoclonal, Humanized / PCSK9 Inhibitors Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Circ J Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2021 Document type: Article